CUSIP: 03674U201
Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
8,470,769
-
Share change
-
0
-
Total reported value
-
$26,006,682
-
Price per share
-
$3.07
-
Number of holders
-
27
Quarterly Holders Quick Answers
What is CUSIP 03674U201?
CUSIP 03674U201 identifies ANTH - ANTHERA PHARMACEUTICALS INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03674U201:
Institutional Holders of ANTHERA PHARMACEUTICALS INC - COM NEW (ANTH) as of Q4 2013
As of 31 Dec 2013,
ANTHERA PHARMACEUTICALS INC - COM NEW (ANTH) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,470,769 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, DEERFIELD MANAGEMENT CO, ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, Broadfin Capital, LLC, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., MOORE CAPITAL MANAGEMENT, LP, and Weiss Multi-Strategy Advisers LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.